AMNEAL PHARMACT Revenue, Profits - AMRX Quarterly Income Statement

Add to My Stocks
$18.84 $0.69 (3.53%) AMRX stock closing price Jun 19, 2018 (Closing)
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q4
AMNEAL PHARMACT Revenues or Net Sales
142.35M182.91M206.39M202.08M184.4M198.42M227.91M172.59M225.51M282.09M
Cost Of Goods Sold (COGS)112.07M170.45M172.35M129.67M159.51M359.69M393.33M99.6M122.91M167.32M
AMNEAL PHARMACT Gross Profit
30.28M12.47M34.03M72.4M24.89M-161.25M-165.42M72.98M102.59M114.78M
Research & Development Expense12.29M202.43M15.82M26.84M28.56M43.79M48.88M21.74M19.02M26.4M
Selling General & Admin Expense142.86M116.71M55.22M52.78M48.12M58.89M58.31M46.83M45.61M57.58M
Income Before Depreciation Depletion Amortization-124.87M-306.66M-37.01M-7.22M-51.8M-263.91M-272.62M4.4M37.95M30.8M
Depreciation Depletion Amortization----------
Non Operating Income-9.58M-1.76M-0.34M-2.34M6.46M-0.15M--47.11M-9.36M
Interest Expense13.69M13.04M13.63M13.36M13.38M13.58M11.08M8.45M8.33M8.16M
AMNEAL PHARMACT Pretax Income
-138.22M-310.09M-52.41M-20.93M-67.53M-271.02M-283.86M-3.95M-17.49M13.27M
Provision for Income Taxes-7.29M-9.02M-3.04M-0.52M30.9M8.56M-104.53M-1.24M-7.08M1.86M
MinorityInterest----------
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations-130.93M-301.07M-49.37M-20.42M-98.43M-279.59M-179.34M-2.7M-10.41M11.43M
Extraordinary Items & Discontinued Operations----------
AMNEAL PHARMACT Profit/ Loss (Net Income)
-130.93M-301.07M-49.37M-20.42M-98.43M-279.59M-179.34M-2.7M-10.41M11.43M
Average Shares used to compute Diluted EPS-72.1M71.93M71.8M71.6M71.49M71.33M71.1M70.67M72.04M
Average Shares used to compute Basic EPS-72.1M71.93M71.8M71.6M71.49M71.33M71.1M70.67M70.42M
Income Before Nonrecurring Items-7.64M16.68M13.14M7.73M11.65M26.15M15.01M30.85M44.52M
Income from Nonrecurring Items--308.71M-66.05M-33.56M-106.16M-291.23M-205.49M-17.71M-41.26M-33.09M
AMNEAL PHARMACT Earnings Per Share Basic Net
-1.81-4.18-0.69-0.28-1.37-3.91-2.51-0.04-0.150.16
AMNEAL PHARMACT Earnings Per Share Diluted Net
-1.81-4.18-0.69-0.28-1.37-3.91-2.51-0.04-0.150.16
EPS Diluted Before Nonrecurring Items-0.110.230.180.110.160.370.210.430.62
Preferred Dividends Acc Pd----------
Dividends Common0.000.00--------
Dividend Per Share Common0.000.000.000.000.000.000.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

AMNEAL PHARMACT Income Statement - Key Financial Ratios

PS Ratio (price sales ratio)
1.85
Dividend Yield
0%